A new novolimus-eluting bioresorbable coronary scaffold: Present status and future clinical perspectives

详细信息    查看全文

• 作者：Holger M. Nef^a ; ¹ ; Jens Wiebe^b ; ¹ ; Nicolas Foin^c ; ¹ ; Florian Blachutzik^d ; ¹ ; ^{florian.blachutzik@uk-erlangen.de} ; Oliver D&ouml ; rr^a ; ¹ ; Sara Toyloy^e ; ¹ ; Christian W. Hamm^a ; ¹
• 关键词：Percutaneous coronary intervention ; Novolimus-eluting bioresorbable vascular scaffold ; Coronary artery disease
• 刊名：International Journal of Cardiology
• 出版年：2017
• 出版时间：15 January 2017
• 年：2017
• 卷：227
• 期：Complete
• 页码：127-133
• 全文大小：1422 K
• 卷排序：227

文摘

DESolve® has demonstrated preclinical and clinical safety and effectiveness. DESolve® has demonstrated a restoration of vasomotion after implantation. DESolve® possesses “self-correction” property. DESolve® Cx platform is the first scaffold to have a 120 μm strut thickness.